Rowena Bergman

Bio:

Rowena is a seasoned healthcare analytics leader with over two decades of experience transforming how pharmaceutical and healthcare companies measure and optimize their communications impact. Her innovative approaches to measurement and analytics have revolutionized how global brands demonstrate and enhance their business value, transforming complex data into compelling insights and stories. 

Her extensive healthcare analytics portfolio includes work with many of the world's leading pharmaceutical companies such as Pfizer, Abbott, Novartis, Boehringer Ingelheim, Novo Nordisk, Mylan, Merck, Johnson & Johnson, and AstraZeneca. She has developed sophisticated measurement frameworks for branded and unbranded campaigns, patient journey analytics, and clinical recruitment strategies that consistently deliver meaningful business results. 

A recognized industry leader and PM360 ELITE Digital Crusader, Rowena has pioneered new methodologies that make healthcare measurement more efficient and actionable. Her expertise in extracting insights from complex data sets has proven invaluable in optimizing communications across healthcare professionals, key opinion leaders, patient, and caregiver audiences. 

While healthcare is her primary focus, Rowena's analytics leadership spans multiple industries. She has developed measurement programs for Fortune 500 brands across technology, consumer, automotive, and entertainment sectors. This diverse background has enabled her to pioneer innovative approaches in healthcare analytics, particularly in digital and social media measurement. Her cross-industry expertise brings a valuable perspective to healthcare communications, helping organizations leverage advanced measurement techniques and stay ahead of evolving digital landscapes.